Nonalcoholic fatty liver disease(NAFLD) - Globe Thesis

Keyword [Nonalcoholic fatty liver disease(NAFLD)] Result: 21 - 40 \| Page: 2 of 4
21.	Extract Of Bulbus Allium Fistulosum Combined With Acupuncture Therapy In Treatment Of Nonalcoholic Fatty Liver Disease(Phlegm And Blood Stasis Type) Clinical Observation
22.	The Study Of Sapindus Alcoholic Extract On Non-alcoholic Fatty Liver Disease In Rats
23.	The Dynamic Expression Significance Of PACS-2in Non-alcoholic Fatty Liver Disease
24.	Comparative Study Of The MRI With Hispathology In Quantifying Hepatic Steatosis
25.	Effects Of Exenatide On The Expression Of FTO Induced By High-fat In L02Cells And Its Mechanisms
26.	Effect Of Insulin And Insulin Secretagogues On Non-alcoholicFatty Liver In Patients With Type2Diabetes Mellitus
27.	Research On The Role Of Exenatide In Nonalcoholic Fatty Liver Disease (NAFLD) And The Molecular Mechanism Of It Regulates The Homocysteine (Hcy)
28.	Study On The Regulation Of Gene Expression Or Gene Control Of Obesity And Non-alcoholic Fatty Liver Disease
29.	The Study Of Correlation Of MRI-DWI, ~1H-MRS And LDL-C In NAFLD
30.	Research Of The Efficacy And Mechanism Of Schisandrin B (SchB) In Nonalcoholic Fatty Liver Disease (NAFLD)
31.	Therapeutical Effect Of Resveratrol On The Nonalcoholic Fatty Liver Disease Rat Model And Its Potential Mechanism
32.	The Effect Of IGF-1 On Expression Of P38MAPK And Biochemical Indexes In Steatosis Hepatocyte
33.	Research On The Mechanism Of Xiaozhi Yigan Decoction For The Prevention And Treatment Of Non-alcoholic Fatty Liver Disease In Rats Induced With High-fat Diet
34.	Autophagy Suppresses NLRP3 Inflammasome Dependent On TRAF6-mediated K63 Ubiquitination For ASC
35.	Role Of ChREBP And Target Genes PNPLA3in The Pathogenesis Of Nonalcoholic Fatty Liver Disease
36.	Effects Of Liraglutide On The Expression Of LC3Ⅱ、p62 In NAFLD Cell Induced By High-fat In Vitro
37.	The Effects Of Shiweitiaozhi Decoction On The Expression Of MMP-2mRNA And TIMP-2mRNA In Nonalcoholic Fatty Liver Disease Rats
38.	Mutation Of MiR-21 Targets Endogenous Lipoprotein Receptor-related Protein 6 In The Pathogenesis Of Nonalcoholic Fatty Liver Diseaseand Nonalcoholic Fatty Liver Disease
39.	A Meta-Analysis Of The Efficacy And Safety Of Statins In The Treatment Of Nonalcoholic Fatty Liver Disease
40.	Clinical Characteristics And Significance Of Metabolically Healthy Obese Individuals
<<First <Prev Next> Last>> Jump to